Company Profile

Daktari Diagnostics Inc
Profile last edited on: 12/26/19      CAGE: 5JP76      UEI: RCJGQUV3YTD5

Business Identifier: Portable point-of-care diagnostic platform for disease management:Virology,(HCV and HIV detection) InSight (data Management) ;Sickle Cell
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

85 Bolton Street
Cambridge, MA 02140
   (617) 336-3299
Location: Single
Congr. District: 07
County: Middlesex

Public Profile

Indicated as now closed down, Daktari Diagnostics, Inc. had been a biotechnology and medical device company focused to medical diagnostic equipment enabling enhanced disease management in both developed and developing countries. The firm's portable point-of-care diagnostic platform, with built-in wireless connectivity and an intuitive cloudbased data management system, provides the real-time information necessary to improve clinical outcomes for individual patients and support global disease elimination programs. Daktari’s initial products will target viruses of worldwide significance, including Hepatitis C and HIV. The company recently announced a Hepatitis C partnership with Merck & Co (MSD). Daktari has three main products in development. First. CD4 system, a portable and robust blood test-based diagnostic system that utilizes Daktari's proprietary technologies in microfluidics and electrochemical sensing. The system is battery powered and utilizes a single use microfluidic assay cartridge. Particularly targeted at HIV treatment, the devices is able to deliver an accurate white-blood cell count. Second, Daktari is developing a data management system that enables its devices to securely communicate with medical systems and databases. Finally, early-stage development has begun on a device to measure viral load in patients. Some of the technologies underpinning Daktari's products were licensed from Massachusetts General Hospital

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Donald B Hawthorne -- Former President and CEO

  Robert Etheredge -- Former Vice President, Innovation

  Marta Fernandez-Suarez

  Tiana Veldwischtveldwisch

  Betsy Wonderly Trainor